Adverse drug reactions caused by drug-drug interactions in elderly outpatients: a prospective cohort study
Contribuinte(s) |
UNIVERSIDADE DE SÃO PAULO |
---|---|
Data(s) |
05/11/2013
05/11/2013
2012
|
Resumo |
Although the prevalence of drug-drug interactions (DDIs) in elderly outpatients is high, many potential DDIs do not have any actual clinical effect, and data on the occurrence of DDI-related adverse drug reactions (ADRs) in elderly outpatients are scarce. This study aimed to determine the incidence and characteristics of DDI-related ADRs among elderly outpatients as well as the factors associated with these reactions. A prospective cohort study was conducted between 1 November 2010 and 31 November 2011 in the primary public health system of the Ourinhos micro-region, Brazil. Patients aged a parts per thousand yen60 years with at least one potential DDI were eligible for inclusion. Causality, severity, and preventability of the DDI-related ADRs were assessed independently by four clinicians using validated methods; data were analysed using descriptive analysis and multiple logistic regression. A total of 433 patients completed the study. The incidence of DDI-related ADRs was 6 % (n = 30). Warfarin was the most commonly involved drug (37 % cases), followed by acetylsalicylic acid (17 %), digoxin (17 %), and spironolactone (17 %). Gastrointestinal bleeding occurred in 37 % of the DDI-related ADR cases, followed by hyperkalemia (17 %) and myopathy (13 %). The multiple logistic regression showed that age a parts per thousand yen80 years [odds ratio (OR) 4.4; 95 % confidence interval (CI) 3.0-6.1, p < 0.01], a Charlson comorbidity index a parts per thousand yen4 (OR 1.3; 95 % CI 1.1-1.8, p < 0.01), consumption of five or more drugs (OR 2.7; 95 % CI 1.9-3.1, p < 0.01), and the use of warfarin (OR 1.7; 95 % CI1.1-1.9, p < 0.01) were associated with the occurrence of DDI-related ADRs. With regard to severity, approximately 37 % of the DDI-related ADRs detected in our cohort necessitated hospital admission. All DDI-related ADRs could have been avoided (87 % were ameliorable and 13 % were preventable). The incidence of ADRs not related to DDIs was 10 % (n = 44). The incidence of DDI-related ADRs in elderly outpatients is high; most events presented important clinical consequences and were preventable or ameliorable. Fundacao de Apoio ao Desenvolvimento Cientifico (FADEC) Fundacao de Apoio ao Desenvolvimento Cientifico (FADEC) |
Identificador |
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, HEIDELBERG, v. 68, n. 12, supl. 1, Part 2, pp. 1667-1676, DEC, 2012 0031-6970 http://www.producao.usp.br/handle/BDPI/41458 10.1007/s00228-012-1309-3 |
Idioma(s) |
eng |
Publicador |
SPRINGER HEIDELBERG HEIDELBERG |
Relação |
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY |
Direitos |
closedAccess Copyright SPRINGER HEIDELBERG |
Palavras-Chave | #DRUG INTERACTIONS #DRUG TOXICITY #AGE #OUTPATIENTS #COHORT STUDIES #PHARMACOVIGILANCE #NONSTEROIDAL ANTIINFLAMMATORY DRUGS #IN-HOSPITAL INPATIENTS #DIGITALIS GLYCOSIDES #MANIFESTATIONS #HYPERKALEMIA #PREVALENCE #MECHANISMS #RELEVANCE #TOXICITY #THERAPY #PHARMACOLOGY & PHARMACY |
Tipo |
article original article publishedVersion |